Lacunar Stroke Associated with Methylphenidate Abuse

Canadian Journal of Neurological Sciences

Volumn 31, Issue 1, 2004, Pages 109-111

  Sadeghian, Hamid ^a,b  

^a SHAHID BEHESHTI UNIVERSITY   (Iran)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CENTRAL STIMULANT AGENT; CONTRAST MEDIUM; DOPAMINE; METHYLPHENIDATE; PIPERIDINE DERIVATIVE;

ADULT; ATTENTION DEFICIT DISORDER; BRAIN INFARCTION; CASE REPORT; CHRONIC DRUG ADMINISTRATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DISEASE COURSE; DRUG ABUSE; DRUG UTILIZATION; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NARCOLEPSY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE;

EID: 1542374139     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100002924     Document Type: Review

References (32)

1. Challman TD, Lipsky JJ. Methylphenidate: its pharmacology and uses. Mayo Clin Proc 2000; 75: 711-721.
2. Jansen IH, Olde Rikkert MG, Hulsbos HA, Hoefnagels WH. Toward individualized evidence-based medicine: five "N of 1" trials of methylphenidate in geriatric patients. J Am Geriatr Soc 2001; 49: 474-476.
3. Johnson ML, Roberts MD, Ross AR, Witten CM. Methylphenidate in stroke patients with depression. Am J Phys Med Rehabil 1992; 71(4): 239-241.
4. Glenn MB. Methylphenidate for cognitive and behavioral dysfunction after traumatic brain injury. J Head Trauma Rehabil 1998; 13: 87-90.
5. Rozans M, Dreisbach A, Lertora JJ, Kahn MJ. Palliative uses of methylphenidate in patients with cancer: a review. J Clin Oncol 2002; 20: 335-339.
6. Hinkin CH, Castellon SA, Hardy DJ, et al. Methylphenidate improves HIV-1-associated cognitive slowing. J Neuropsychiatry Clin Neurosci 2001; 13: 248-254.
7. Vastag B. Pay attention: Ritalin acts much like cocaine. JAMA 2001; 286: 905-906.
8. Meririnne E, Kankaanpaa A, Seppala T. Rewarding properties of methylphenidate: sensitization by prior exposure to the drug and effects of dopamine D1- and D2-receptor antagonists. J Pharmacol Exp Ther 2001; 298: 539-550.
9. Jones SR, Joseph JD, Barak LS, Caron MG, Wightman RM. Dopamine neuronal transport kinetics and effects of amphetamine. J Neurochem 1999; 73: 2406-2414.
10. Martinez-Cano H, Martinez-Gras I, De Iceta M, Rodao JM, Vela-Bueno A. Methylphenidate in stimulants abuse: three case reports. Am J Addict 2001; 10: 192-193.
11. Rappley MD. Safety issues in the use of methylphenidate. An American perspective. Drug Safety 1997; 17: 143-148.
12. Babcock O, Byrne T. Student perceptions of methylphenidate abuse at a public liberal arts college. J Am Coll Health 2000; 49: 143-145.
13. Weiner AL. Emerging drugs of abuse in Connecticut. Conn Med 2000; 64: 19-23.
14. Klein-Schwartz W. Abuse and toxicity of methylphenidate. Curr Opin Pediatr 2002; 14: 219-223.
15. Lipkin PH, Goldstein IJ, Adesman AR. Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder. Arch Pediatr Adolesc Med 1994; 148: 859-861.
16. Parran TV Jr, Jasinski DR. Intravenous methylphenidate abuse: prototype for prescription drug abuse. Arch Intern Med 1991; 151: 781-783.
17. Still A, Gordon M, Mercer J, Roake J. Ritalin: drug of abuse. Two case reports of intra-arterial injection. N Z Med J 2001; 114: 521-522.
18. Jaffe SL. Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD. J Am Acad Child Adolesc Psychiatry 1991; 30: 773-775.
19. Stecyk O, Loludice TA, Demeter S, Jacobs J. Multiple organ failure resulting from intravenous abuse of methylphenidate hydrochloride. Ann Emerg Med 1985; 14: 597-599.
20. Kishorekumar R, Yagnik P, Dhopesh V. Acute myelopathy in a drug abuser following an attempted neck vein injection. J Neurol Neurosurg Psychiatry 1985; 48: 843-844.
21. Zemplenyi J, Colman MF. Deep neck abscesses secondary to methylphenidate (Ritalin) abuse. Head Neck Surg 1984; 6: 858-860.
22. Sherman CB, Hudson LD, Pierson DJ. Severe precocious emphysema in intravenous methylphenidate (Ritalin) abusers. Chest 1987; 92: 1085-1087.
23. Massello W 3rd, Carpenter DA. A fatality due to intranasal abuse of methylphenidate (Ritalin). J Forensic Sci 1999; 44: 220-221.
24. Harrington H, Heller HA, Dawson D, et al. Intracerebral hemorrhage and oral amphetamine. Arch Neurol 1983; 40: 503-507.
25. Brust JCM. Stroke and substance abuse. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM, (Eds). Stroke: pathophysiology, diagnosis, and management. Philadelphia: Churchill Livingstone, 1998: 979-1000.
26. Levine SR, Brust JCM, Futrell N, et al. Cerebrovascular complications of the use of the "crack" form of alkaloidal cocaine. N Eng J Med 1990; 323: 699-704.
27. Edwards M, Russo L, Harwood-Nuss A. Cerebral infarction with a single oral dose of phenylpropanolamine. Am J Emerg Med 1987; 5: 163-164.
28. Perez JA Jr, Arsura EL, Strategos S. Methamphetamine-related stroke: four cases. J Emerg Med 1999; 17; 469-471.
29. Hanyu S, Ikeguchi K, Imai H, Imai N, Yoshida M. Cerebral infarction associated with 3,4-methylenedioxymethamphetamine ('Ecstasy') abuse. Eur Neurol 1995; 35: 173.
30. Rumbaugh CL, Fang HCH, Higgins RE, et al. Cerebral microvascular injury in experimental drug abuse. Invest Radiol 1976; 11: 282-294.
31. Trugman JM. Cerebral arteritis and oral methylphenidate. Lancet 1988; 1 (8585): 584-585.
32. Schteinschnaider A, Plaghos LL, Garbugino S, et al. Cerebral arteritis following methylphenidate use. J Child Neurol 2000; 15: 265-267.